EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

NRF2 and Aquaglyceroporins: Orchestrating Metabolic and Redox Homeostasis in Cancer Resistance

Monika Mlinarić, Anita Bijelić, Ana Josipa Jerončić, Juraj Kolak, Kristina Kanceljak, Martina Matec, Anita Zenko Sever, Hrvoje Silovski, Tajana Silovski, Ana Čipak Gašparović

Antioxidants · 06.11.2026 · 15 (11) · 1439

DOI: 10.3390/antiox15111439 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antioxidants, online erschienen am 06.11.2026. Verfasst von Monika Mlinarić und 9 weiteren Autor:innen. Die Arbeit nennt 247 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: HRZZ, Croatian Society for Medical Oncology/Croatian Medical Association.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer remains a primary global health challenge, characterized by high metabolic plasticity and therapy resistance. A critical factor in tumor survival is the fine-tuning of redox homeostasis, governed by the NRF2 signaling pathway. This redox balance is inevitably linked to the cellular metabolic network, where NRF2 drives the pentose phosphate pathway, NADPH production, and lipid metabolism to fuel rapid proliferation and drug detoxification. Recent evidence highlights a functional link between NRF2 and specific aquaporin (AQP) isoforms, peroxiporins and aquaglyceroporins, which facilitate the transmembrane flux of hydrogen peroxide and glycerol. By regulating the movement of these molecules, AQPs can actively contribute to both metabolic reprogramming and redox signaling. This review explores the mechanisms of NRF2 and AQP co-regulation in breast, colon, and liver cancers, illustrating their combined role in driving tumor progression and malignancy. Furthermore, we evaluate the clinical potential of targeting these pathways and discuss the utility of NRF2/AQP co-expression as a predictive biomarker for therapy outcomes. Identifying these molecular signatures offers a promising avenue for patient stratification and the development of novel therapeutic strategies to overcome tumor resistance.

Förderung

  • HRZZ
  • Croatian Society for Medical Oncology/Croatian Medical Association

Zitieren

APA

Mlinarić, M., Bijelić, A., Jerončić, A. J., Kolak, J., Kanceljak, K., Matec, M., Sever, A. Z., Silovski, H., Silovski, T., & Gašparović, A. Č. (2026). NRF2 and Aquaglyceroporins: Orchestrating Metabolic and Redox Homeostasis in Cancer Resistance. Antioxidants, 15(11), 1439. https://doi.org/10.3390/antiox15111439

Vancouver

Mlinarić M, Bijelić A, Jerončić AJ, Kolak J, Kanceljak K, Matec M, et al. NRF2 and Aquaglyceroporins: Orchestrating Metabolic and Redox Homeostasis in Cancer Resistance. Antioxidants. 2026;15(11):1439. doi:10.3390/antiox15111439

BibTeX
@article{Mlinari2026,
  author = {Mlinarić, Monika and Bijelić, Anita and Jerončić, Ana Josipa and Kolak, Juraj and Kanceljak, Kristina and Matec, Martina and Sever, Anita Zenko and Silovski, Hrvoje and Silovski, Tajana and Gašparović, Ana Čipak},
  title = {NRF2 and Aquaglyceroporins: Orchestrating Metabolic and Redox Homeostasis in Cancer Resistance},
  journal = {Antioxidants},
  year = {2026},
  volume = {15},
  number = {11},
  pages = {1439},
  doi = {10.3390/antiox15111439}
}
Kostenlos starten →